Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel

Dede, D.; Gumuskaya, B.; Guler, GÜLNUR; Onat, D.; Altundag, K.; Ozisik, Y.

Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel

Copy For Citation

Dede D. S., Gumuskaya B., Guler G., Onat D., Altundag K., Ozisik Y.

JOURNAL OF BUON, vol.18, no.1, pp.57-63, 2013 (SCI-Expanded)

Publication Type: Article / Article
Volume: 18 Issue: 1
Publication Date: 2013
Journal Name: JOURNAL OF BUON
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.57-63
Hacettepe University Affiliated: Yes

Abstract

Purpose: To assess the changes of biologic markers estrogen receptors (ER), progesterone receptors (PR), HER 2 and Ki-67 in locally advanced breast cancer patients after neoadjuvant chemotherapy.